小梁骨评分与中轴型脊柱关节炎患者椎体骨折的相关性
纳入255例符合国际脊柱关节炎评估协会中轴型脊柱关节炎影像学标准患者,比较有无椎体骨折者的小梁骨评分并分析其与椎体骨折的关联。28/255例(11%)存在椎体骨折,骨折者小梁骨评分更低(1.30 vs 1.39,P<0.001),低小梁骨评分(<1.23)与椎体骨折相关(OR 5.3,95%CI 2.0-14.1)。
要点
- 中轴型脊柱关节炎患者椎体骨折者小梁骨评分较无骨折者更低(1.30 vs 1.39,P<0.001)。
- 低小梁骨评分(<1.23)与椎体骨折相关(OR 5.3,95%CI 2.0-14.1)。
- 小梁骨评分预测椎体骨折的区分能力优于全髋骨密度(P=0.034)。
核心结论
- 与原发性骨质疏松个体类似,中轴型脊柱关节炎伴椎体骨折患者的小梁骨评分更低,提示小梁骨评分有潜力预测中轴型脊柱关节炎患者未来椎体骨折。
研究设计与样本
- 纳入255例符合国际脊柱关节炎评估协会中轴型脊柱关节炎影像学标准的患者,采用双能量X线吸收法评估小梁骨评分与骨密度,按Genant标准定义胸腰椎椎体骨折,并进行单因素logistic回归分析。
主要发现
- 28/255例中轴型脊柱关节炎患者(11%)共存在31处椎体骨折。
- 无椎体骨折者与有椎体骨折者的平均(标准差)小梁骨评分分别为1.39(0.11)与1.30(0.13)(P<0.001)。
- 有椎体骨折者股骨颈骨密度更低(P=0.027),而腰椎与全髋骨密度未见差异。
- 单因素logistic回归显示高龄(⩾50岁)、TNF抑制剂治疗、存在韧带骨赘和低小梁骨评分(<1.23)与现患椎体骨折相关,比值比(95%CI)分别为6.9(2.0, 24.4)、2.4(1.0, 5.5)、5.5(2.2, 13.5)和5.3(2.0, 14.1)。
- 小梁骨评分对中轴型脊柱关节炎患者椎体骨折的预测区分能力优于全髋骨密度(P=0.034)。
关键数值与推荐
- 椎体骨折按Genant标准定义。
- 低小梁骨评分定义为<1.23。
- 高龄定义为⩾50岁。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare trabecular bone scores (TBS) between axial SpA (axSpA) patients with and without vertebral fractures and investigate associations between TBS and vertebral fractures. METHODS: Two hundred and fifty-five patients fulfilling the imaging arm of the Assessment of SpondyloArthritis International Society axSpA criteria were enrolled. TBS and BMD were assessed using dual-energy X-ray absorptiometry. Vertebral fracture of the thoracic and lumbar spine was defined according to the Genant criteria. Osteoporosis risk factors, inflammatory markers, DAS and spinal structural damage were also assessed. Univariate logistic regression analysis was performed to identify factors associated with vertebral fractures. RESULTS: There were 31 vertebral fractures in 28/255 axSpA patients (11%). The mean (s.d.) TBS was 1.39 (0.11) and 1.30 (0.13) in patients without and with vertebral fractures, respectively (P < 0.001). BMD in the femoral neck was lower in patients with vertebral fractures (P = 0.027), but BMDs in the lumbar spine and total hip were not. Univariate logistic regression analyses identified old age (⩾50 years), TNF inhibitor treatment, the presence of syndesmophytes and a low TBS (<1.23) as associated with prevalent vertebral fractures [odds ratio (95% CI): 6.9 (2.0, 24.4), 2.4 (1.0, 5.5), 5.5 (2.2, 13.5) and 5.3 (2.0, 14.1), respectively]. TBS has a better discriminatory value than BMD at the total hip for prediction of vertebral fractures in axSpA patients (P = 0.034). CONCLUSION: Similar to individuals with primary osteoporosis, axSpA patients with vertebral fractures have a lower TBS. This suggests that TBS has the potential to predict future vertebral fractures in patients with axSpA.
引用
- Kang KY, Kim IJ, Park SH, et al. Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford). 2018. PMID: 29534215. doi:10.1093/rheumatology/key027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。